PCV82 VALIDATION OF A MODEL TO PREDICT LIFETIME CLINICAL AND ECONOMIC BENEFIT OF RAISING HDL-C IN STATINTREATED PATIENTS WITH PERSISTENTLY LOW HDL-C

Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63697-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63697-2/fulltext
Title : PCV82 VALIDATION OF A MODEL TO PREDICT LIFETIME CLINICAL AND ECONOMIC BENEFIT OF RAISING HDL-C IN STATINTREATED PATIENTS WITH PERSISTENTLY LOW HDL-C
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63697-2&doi=10.1016/S1098-3015(10)63697-2
First page :
Section Title :
Open access? : No
Section Order : 549
Categories :
Tags :
Regions :
ViH Article Tags :